Ohcanbohtosat - Ashok K. Shakya

Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update Dahkki Rajashri R. Naik, Ashok K. Shakya

Connect to this object online.

Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cance... Dahkki Sewar G. Shnaikat, Ashok K. Shakya, Sanaa K. Bardaweel

Connect to this object online.

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19 Dahkki Rajashri R. Naik, Rajashri R. Naik, Ashok K. Shakya, Ashok K. Shakya, Safwan M. Aladwan, Mohamed El-Tanani, Mohamed El-Tanani, Mohamed El-Tanani, Mohamed El-Tanani

Connect to this object online.

Formulation and release of timolol maleate from ocusert based on gelatin-N-(3-dimethylaminopropyl)-N-ethylcarbodiimide polymer Dahkki Mohammed Q. Kanaan, Nawfal A. Numan, Ashok K. Shakya, Fatima A. Tawfiq

Connect to this object online.

Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as non-steroidal anti-inflammatory agents Dahkki Ashok K. Shakya, Avneet Kaur, Belal O. Al-Najjar, Rajashri R. Naik

Connect to this object online.

Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients Dahkki Mohamed El-Tanani, Khaled Abdul-Aziz Ahmed, Ashok K. Shakya, Wesam G. Ammari, Abdel-E

Connect to this object online.